DELPHI GENETICS
With a core business in plasmid DNA and genetic engineering, Delphi Genetics provides services based on unique technologies. To assist you in your viral, and non-viral, gene therapy programs, our dedicated team of scientists develop customized GMP plasmid DNA manufacturing solutions. Their patented STABY® technology without antibiotic resistance gene is the ideal alternative to standard antibiotic-resistance selection and drives better plasmid DNA stabilization.
DELPHI GENETICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2001-01-01
Address:
Charleroi, Hainaut, Belgium
Country:
Belgium
Website Url:
http://www.delphigenetics.com
Total Employee:
11+
Status:
Active
Contact:
+32 (0).71.25.10.00
Email Addresses:
[email protected]
Technology used in webpage:
Amazon GoDaddy DNS Person Schema Facebook Sharer Gravatar Profiles AWS Global Accelerator
Similar Organizations
AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals engages in developing, marketing, and distributing medicines for orphan indications and complex diseases.
Beryllium Discovery
Beryllium Discovery is a specialized drug discovery contract research organization (CRO), provides research services.
Current Employees Featured
Founder
Official Site Inspections
http://www.delphigenetics.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Delphi Genetics"
Delphi Genetics - Crunchbase Company Profile
With a core business in plasmid DNA and genetic engineering, Delphi Genetics provides services based on unique technologies. To assist you in your viral, …See details»
Catalent to Acquire Delphi Genetics and Launch US …
Feb 23, 2021 SOMERSET, N.J. and GOSSELIES, BELGIUM – February 23, 2021 — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene …See details»
Delphi Genetics Company Overview, Contact Details
Delphi Genetics 's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology). How …See details»
Delphi Genetics Company Profile | Management and Employees …
Delphi Genetics' patented "antibiotic-free" Stab y® technology increases the yield of recombinant protein or plasmid DNA production in E. coli compared to the traditional approach with …See details»
Delphi Genetics SA - Ownership and Business Overview - Mergr
Delphi Genetics SA is a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization (CDMO). Delphi Genetics was founded in 2001 and is based in …See details»
Delphi Genetics Company Profile - Office Locations, Competitors
Delphi Genetics is a company that specializes in bioproduction of plasmid DNA and recombinant proteins including antibodies. It develops the Staby technology that increases the yield of …See details»
Delphi Genetics acquired by Catalent Pharma Solutions - Crunchbase
Feb 23, 2021 Delphi Genetics Delphi Genetics is a core business in plasmid DNA and genetic engineering, Delphi Genetics provides services Acquiring Organization: Catalent Pharma …See details»
Delphi Genetics - VentureRadar
Goodwin Biotechnology USA n/a We are a biological contract manufacturing organization (CMO) with more than two decades of experience and expertise in the development as well as …See details»
☑️Delphi Genetics — Consulting Organization from Belgium, …
Dec 27, 2022 Delphi Genetics — Consulting Organization from Belgium, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Science & Innovation sectors Our website …See details»
Delphi Genetics - Owler
Delphi Genetics’s Profile, Revenue and Employees. Delphi Genetics is a contract development and manufacturing organization that commercializes cell and gene therapies for the …See details»
Catalent to Acquire Delphi Genetics and Launch US …
Feb 23, 2021 SOMERSET, N.J. and GOSSELIES, BELGIUM – February 23, 2021 — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene …See details»
Delphi Genetics - Company Profile - Tracxn
Feb 27, 2025 Delphi Genetics. has raised a total funding of $1.09M over 2 rounds. Its first funding round was on Mar 10, 2015. What are the most recent funding rounds of Delphi …See details»
Catalent to Acquire Delphi Genetics - News-Medical.net
Feb 26, 2021 Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and …See details»
Catalent Acquires Delphi Genetics SA | Mergr M&A Deal Summary
Feb 23, 2021 Delphi Genetics SA is a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization (CDMO). Delphi Genetics was founded in 2001 …See details»
Catalent to Acquire Delphi Genetics and Launch US Plasmid …
Feb 24, 2021 SOMERSET, N.J. and GOSSELIES, BELGIUM — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for …See details»
Catalent to Acquire Delphi Genetics to Expand Plasmid DNA
Catalent announced on Feb. 23, 2021 that it has acquired Delphi Genetics, a Belgium-based plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing …See details»
Delphi Genetics - PitchBook
Delphi Genetics General Information Description. Developer of molecular tools designed to offer deoxyribonucleic acid engineering services. The company's tool is used for synthetic biology, …See details»
Delphi Genetics - Overview, News & Similar companies - ZoomInfo
Delphi Genetics' patented "antibiotic-free" Staby® technology increases the yield of recombinant protein or plasmid DNA production in E. coli compared to the traditional approach with …See details»
Catalent to Acquire Delphi Genetics and Launch US Plasmid …
Feb 23, 2021 Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and …See details»
Toward a consensus on dyslexia: findings from a Delphi study
Feb 25, 2025 Co-occurring difficulties may be seen in aspects of language, motor coordination, mental calculation, concentration, and personal organization, but these are not, by …See details»